Skip to main content Accessibility help

Thirty-Day Laboratory-Based Surveillance for Carbapenem-Resistant Enterobacteriaceae in the Minneapolis-St. Paul Metropolitan Area

  • Edwin C. Pereira (a1), Kristin M. Shaw (a2), Paula M. Snippes Vagnone (a2), Jane E. Harper (a2), Alexander J. Kallen (a3), Brandi M. Limbago (a3) and Ruth Lynfield (a2)...


Carbapenem-resistant Enterobacteriaceae (CRE) are a growing problem in the United States. We explored the feasibility of active laboratory-based surveillance of CRE in a metropolitan area not previously considered to be an area of CRE endemicity. We provide a framework to address CRE surveillance and to monitor changes in the incidence of CRE infection over time.


Corresponding author

420 Delaware Street SE, MMC 250, Minneapolis, MN 55455 (


Hide All
1. Centers for Disease Control and Prevention. Healthcare-associated infections (HAIs): tracking CRE. Published luly 9, 2012. Accessed June 28, 2013.
2. Gupta, N, Limbago, BM, Patel, JB, Kallen, AJ. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis 2011;53(1):6067.
3. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing: Twenty-Second Informational Supplement. Wayne, PA: CLSI, 2012. CLSI document M100-S22.
4. Centers for Disease Control and Prevention. Healthcare-associated infections (HAIs): multiplex real-time PCR detection of Klebsiella pneumoniae carbapenemase (KPC) and New Delhi metallo-β-lactamase (NDM-1) genes. Updated April 20, 2011. Accessed January 30, 2013.


Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed